Structure, dynamics, and selectivity of the sodium channel blocker mu-conotoxin SIIIA.
mu-SIIIA, a novel mu-conotoxin from Conus striatus, appeared to be a selective blocker of tetrodotoxin-resistant sodium channels in frog preparations. It also exhibited potent analgesic activity in mice, although its selectivity profile against mammalian sodium channels remains unknown. We have determined the structure of mu-SIIIA in aqueous solution and characterized its backbone dynamics by NMR and its functional properties electrophysiologically. Consistent with the absence of hydroxyprolines, mu-SIIIA adopts a single conformation with all peptide bonds in the trans conformation. The C-terminal region contains a well-defined helix encompassing residues 11-16, while residues 3-5 in the N-terminal region form a helix-like turn resembling 3 10-helix. The Trp12 and His16 side chains are close together, as in the related conotoxin mu-SmIIIA, but Asn2 is more distant. Dynamics measurements show that the N-terminus and Ser9 have larger-magnitude motions on the subnanosecond time scale, while the C-terminus is more rigid. Cys4, Trp12, and Cys13 undergo significant conformational exchange on microsecond to millisecond time scales. mu-SIIIA is a potent, nearly irreversible blocker of Na V1.2 but also blocks Na V1.4 and Na V1.6 with submicromolar potency. The selectivity profile of mu-SIIIA, including poor activity against the cardiac sodium channel, Na V1.5, is similar to that of the closely related mu-KIIIA, suggesting that the C-terminal regions of both are critical for blocking neuronal Na V1.2. The structural and functional characterization described in this paper of an analgesic mu-conotoxin that targets neuronal subtypes of mammalian sodium channels provides a basis for the design of novel analogues with an improved selectivity profile.
Yao
Shenggen
S
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia.
Zhang
Min-Min
MM
Yoshikami
Doju
D
Azam
Layla
L
Olivera
Baldomero M
BM
Bulaj
Grzegorz
G
Norton
Raymond S
RS
D000818:Animals; D002851:Chromatography, High Pressure Liquid; D020916:Conotoxins / Q000737:chemistry* / Q000494:pharmacology; D008958:Models, Molecular; D019906:Nuclear Magnetic Resonance, Biomolecular; D011487:Protein Conformation; D026941:Sodium Channel Blockers / Q000737:chemistry* / Q000494:pharmacology; D014981:Xenopus
D020916:Conotoxins; D026941:Sodium Channel Blockers
Biochemistry. 1996 Jul 9;35(27):8824-35
8688418
J Neurosci. 1998 Jun 15;18(12):4473-81
9614224
Curr Pharm Des. 2000 Aug;6(12):1249-85
10903392
Protein Sci. 1992 Jun;1(6):736-51
1304915
J Biol Chem. 2007 Oct 19;282(42):30699-706
17724025
J Neurosci. 2000 Jan 1;20(1):76-80
10627583
J Mol Biol. 2008 Apr 4;377(4):1216-27
18295795
Biochemistry. 1992 Dec 22;31(50):12577-84
1335283
Neuron. 2000 Apr;26(1):13-25
10798388
J Biol Chem. 2003 Mar 7;278(10):8717-24
12471026
Nucleic Acids Res. 2008 Jan;36(Database issue):D402-8
17984079
J Mol Biol. 1995 Feb 10;246(1):144-63
7531772
J Biomol NMR. 1999 Mar;13(3):289-302
10212987
J Biol Chem. 2002 Jul 26;277(30):27247-55
12006587
Science. 2001 Mar 23;291(5512):2429-33
11264542
Annu Rev Physiol. 2001;63:871-94
11181979
J Comput Aided Mol Des. 2001 Dec;15(12):1119-36
12160094
J Biomol NMR. 1999 Jan;13(1):83-8
21080267
Biochemistry. 1996 Dec 17;35(50):16009-23
8973171
J Mol Graph. 1996 Feb;14(1):51-5, 29-32
8744573
J Biol Chem. 2003 Nov 21;278(47):46805-13
12970353
Protein Sci. 2001 Mar;10(3):538-50
11344322
J Mol Recognit. 2000 Mar-Apr;13(2):55-70
10822250
Annu Rev Biophys Biophys Chem. 1988;17:451-79
3293595
Biochem Pharmacol. 2008 Jun 15;75(12):2334-44
18486102
J Mol Biol. 1993 Nov 20;234(2):405-20
8230223
Biochemistry. 2000 Apr 11;39(14):3908-19
10747778
Biochemistry. 2002 Dec 24;41(51):15388-93
12484778
J Biomol NMR. 1995 Jul;6(1):1-10
22911575
Nature. 1999 Jul 15;400(6741):289-93
10421374
J Biol Chem. 1985 Aug 5;260(16):9280-8
2410412
Proteins. 2007 Apr 1;67(1):18-30
17256768
J Am Chem Soc. 2001 Jun 27;123(25):6118-26
11414846
Chem Biol. 2007 Apr;14(4):399-407
17462575
Biochemistry. 1991 Jul 16;30(28):6908-16
2069951
Curr Opin Struct Biol. 1997 Oct;7(5):732-7
9345634
J Pept Sci. 2007 Apr;13(4):280-5
17394122
Biochemistry. 2005 May 17;44(19):7259-65
15882064
Biochemistry. 2007 Sep 4;46(35):9929-40
17696362
Biochemistry. 1993 Apr 13;32(14):3571-82
7682109
Toxicon. 2006 Dec 1;48(7):780-98
16952384
Biochemistry. 1994 May 17;33(19):5984-6003
7514039
J Biomol NMR. 1996 Dec;8(4):477-86
9008363
J Biol Chem. 1975 Aug 25;250(16):6368-80
169239
Biochimie. 2000 Sep-Oct;82(9-10):883-92
11086218
J Am Chem Soc. 1977 Jan 5;99(1):79-83
830689
Science. 2002 Feb 22;295(5559):1520-3
11859194
Mol Pharmacol. 2007 Mar;71(3):676-85
17142296
J Magn Reson. 2003 Jan;160(1):65-73
12565051
Proc Natl Acad Sci U S A. 1986 Jul;83(14):5321-5
2425365
J Mol Biol. 2002 May 24;319(1):209-27
12051947